Safety Study Evaluating the Adrenal Suppression Potential of Product 0405 in Pediatric Subjects With Atopic Dermatitis
| Status: | Archived |
|---|---|
| Conditions: | Psoriasis, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | November 2010 |
| End Date: | December 2011 |
An Open-Label Evaluation of the Adrenal Suppression Potential of Product 0405 in the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric Subjects
The aim of the trial is to assess Adrenal Suppression potential when pediatric subjects are
administered Product 0405 for the treatment of Atopic Dermatitis
Treatment medication will be administered topically, twice a day for 4 weeks.
We found this trial at
1
site
Click here to add this to my saved trials
